C50
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - breast cancer patients undergoing adjuvant radiotherapy (with or without lymphatic pathways) - Age =18 years - Performance- Status Karnofsky- Index >60 - Signed informed consent
Exclusion criteria
Exclusion criteria: Absolute: - Instable bone metastases - Myocardial infarction, Angina pectoris or heart disease (NYHA III-IV) in a time period of six months - Arterial hypertension, which is not treated adequately (in therapy >180mmHg systolic; >100mmHg diastolic) - Patients with an increased risk for thrombosis besides underlying disease Relative (inclusion or continuation after recovery possible): - Acute infection (=38,0°Celcius and/ or intravenously therapy with antibiotics) - Thrombocytes < 10x10^9/L - Leukocytes < 1x10^9/L - Hb < 8g/dl
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| performed exercise sessions of IG compared to state of the art [%] (feasibilty of handheld vibration and balance training during radiotherapy) | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint will be assessed pre and post intervention (before radiation therapy and after 6 weeks with termination of radiation therapy) Lymphedema (volume in cm3), postural control (sway path of center of force (COF) in cm), mobility (sec in chair-rising-test), endurance capacity (watt at individual anaerobic threshold (IAT)), quality of life (EORCT-QLQ-C30), fatigue (MFI) | — |
Countries
Germany
Contacts
Universitätsklinik Freiburg Klinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologie und Stammzelltransplantation